Ad is loading...
MENU
SYRS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Syros Pharmaceuticals (SYRS) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

SYRS is expected to report earnings to rise 346.87% to -71 cents per share on March 06

Syros Pharmaceuticals SYRS Stock Earnings Reports
Q4'24
Est.
$-0.71
Q3'24
Beat
by $0.52
Q2'24
Beat
by $0.18
Q1'24
Beat
by $0.75
Q4'23
Est.
$-2.18
The last earnings report on October 31 showed earnings per share of -15 cents, beating the estimate of -68 cents. With 6.32M shares outstanding, the current market capitalization sits at 6.96M.
View a ticker or compare two or three
SYRS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a therapeutics company focusing on discovering and developing novel gene control therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
35 CambridgePark Drive
Phone
+1 617 744-1340
Employees
68
Web
https://www.syros.com